newsfilter
← Latest News
GlobeNewswire·

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

SAN DIEGO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with